首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX
【24h】

Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX

机译:新型香豆素和苯并香豆素可作为与肿瘤相关的碳酸酐酶IX的同工型选择性抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

A series of coumarins and benzocoumarins incorporating methyl and hydroxyl moieties in the heterocyclic ring were investigated for the inhibition of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1). These coumarins were very weak or ineffective as inhibitors of the housekeeping, offtarget isoforms CA I and II, but showed effective, submicromolar inhibition of the transmembrane, tumor-associated isoforms CA IX and to a slightly less extent, CA XII. The nature and position of the groups substituting the coumarin ring influenced CA inhibitory properties. 4-Methyl-5,7-dihydroydroxycoumarin showed KIs 4200 mu M against CA I and II, of 0.19 mu M against CA IX and of 6.4 mu M against CA XII, being thus a selective, efficient inhibitor for the tumor-associated over cytosolic CA isoforms. These compounds are interesting leads for designing isoform-selective enzyme inhibitors.
机译:研究了一系列在杂环中结合了甲基和羟基部分的香豆素和苯并香豆素对锌酶碳酸酐酶的抑制作用(CA,EC 4.2.1.1)。这些香豆素作为管家的脱靶同种型CA I和II的抑制剂非常弱或无效,但是对跨膜,与肿瘤相关的同种型CA IX和CA XII表现出有效的亚微摩尔抑制作用。取代香豆素环的基团的性质和位置影响了CA抑制性能。 4-甲基-5,7-二氢羟基香豆素显示出对CA I和II的KIs为4200μM,对CA IX的KIs为0.19μM,对CA XII的KIs为6.4μM,因此是与细胞溶质相比肿瘤相关的选择性有效抑制剂CA同工型。这些化合物是设计同工型选择性酶抑制剂的有趣线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号